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Aim: There are currently limited lipidomics data for human umbilical cord blood. 
Therefore, the lipidomes of cord sera from six newborns and sera from six nonpregnant 
females were compared. Materials & methods: Sera lipidomics analyses were 
conducted using a high-resolution mass spectrometry analytical platform. Results: 
Cord serum contained a diverse array of glycerophospholipids, albeit generally at lower 
concentrations than monitored in adult serum. The unexpected observations were that 
cord serum contained several neurosteroid sulfates and bile acid sulfates that were not 
detectable in adult serum. Conclusion: Our data are the first to demonstrate that cord 
serum contains bile acid sulfates that are synthesized early in the hydroxylase, neutral 
and acidic pathways of primary bile acid biosynthesis and support previous publications 
of cord blood perfluoralkyl toxins in newborns.
Lay abstract: Umbilical cord blood offers the potential to increase our understanding 
of fetal development during pregnancy and during development after delivery. Our 
studies of complex sterols in umbilical cord blood (bile acid sulfates) suggest that with 
further studies these may be useful biomarkers of abnormal fetal liver development.
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The vessels of the umbilical cord supply the 
fetus with oxygen and nutrients, and remove 
fetal waste products. Even though percuta-
neous umbilical cord blood sampling has 
been an established method for obtaining 
samples for fetal genetic testing during the 
last decades, limited evaluation of umbilical 
cord blood lipidomics has been undertaken 
thus far [1,2]. To define the lipidomics differ-
ences between the lipid profiles of cord sera 
and adult female sera, we undertook a nontar-
geted pilot study of cord lipidomics utilizing a 
high-resolution mass spectrometric platform. 
This involved an evaluation of cord sera from 
six healthy newborns and compared their lipid 
profiles with those of the healthy nonpregnant 
adult females. Nonpregnant adult females 
were chosen as the controls so that the baseline 
measurements were not complicated by the 
fluid communications between the fetus and a 
pregnant mother. Our data add to the human 
cord blood lipidomics database covering glyc-
erophospholipids, s phingolipids, neutral lipids 
and free fatty acids.
Cord serum contained a diverse array 
of glycerophospholipids, albeit generally at 
lower concentrations than monitored in adult 
serum. No major differences in the diversity 
or levels of sphingolipids were detected. In 
contrast, cord serum levels of neutral lipids 
(diacylglycerols [DAG] and triacylglycerols 
[TAG]) were dramatically lower than adult 
serum. Levels of free fatty acids were simi-
lar. We were also able to describe for the first 
time that cord serum contains levels of bile 
acid sulfates not detected in adult serum.
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Materials & methods
Blood collection & processing
Umbilical cord arterial blood was collected at partu-
rition, according to an Ethics Committee-approved 
protocol. Serum was collected and frozen at -80°C 
prior to sample processing. Blood was also collected 
for three male and three female newborn infants. 
Control adult female serum was collected from six 
nonpregnant women (age 32–40 years).
Lipidomics analyses of serum
Lipid profiles were analyzed for all serum samples as fol-
lows. After thawing, 100 μl aliquots of serum were mixed 
with 1 ml of methanol containing stable-isotope internal 
Figure 1. Umbilical cord serum levels of phosphatidylcholines and choline plasmalogens. Mean ± SD. The 
nomenclature refers to the fatty acid or fatty alcohol substitutions at sn-1 and sn-2 of the glycerol backbone. For 
example, 32:1 refers to 32 carbons with one double bond.   
*p < 0.01.  
PlsC: Choline plasmalogen; PtdC: Phosphatidylcholine; R: Ratio of peak area of endogenous lipid to the peak area 
of the internal standard.
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standards [3,4]. Next, 1 ml of water and 2 ml of methyl-
tert-butyl ether were added and the tubes were vigorously 
shaken at room temperature for 30 min. After centrifuga-
tion at 3000 × g for 10 min, 1 ml of the upper organic layer 
was dried by centrifugal vacuum evaporation prior to dis-
solution in 150 μl of isopropanol:methanol:chloroform 
(4:2:1) containing 15 mM ammonium acetate. Shot-
gun ESI lipidomics (5 μl/min) was performed utilizing 
high-resolution data acquisition (140,000 at 200 amu; 
0.3–3 ppm mass error; m/z 200–1400) with an orbitrap 
mass spectrometer (Thermo Q Exactive).
In negative-ion ESI (3.2 kV, capillary temperature of 
320°C, sheath gas of 10), the anions of ethanolamine 
plasmalogens (PlsEtn), phosphatidylglycerols (PG), 
phosphatidylinositols (PtdIn), sterol sulfates, free fatty 
acids and perfluoroalkyl toxins, and the [M + HCOO]- 
anions of ceramides were monitored. In positive-ion 
ESI (4.3 kV, capillary temperature of 320°C, sheath 
gas of 10), the cations of choline plasmalogens (PlsCh), 
phosphatidylcholines, ceramides and sphingomyelins 
(SM) and the ammonium adducts of DAG and TAG 
were monitored.
Data are presented as R values (ratio of the endog-
enous lipid peak area to the peak area of an appropriate 
internal standard) per 100 μl of cord or adult serum 
(n = 6).
Figure 2. Umbilical cord serum levels of phosphatidylethanolamines, ethanolamine plasmalogens and 1-alkyl-2-acyl 
glycerophosphoethanolamines. Mean ± SD. The nomenclature refers to the fatty acid or fatty alcohol substitutions 
at sn-1 and sn-2 of the glycerol backbone. For example, 36:4 refers to 36 carbons with four double bonds. 
*p < 0.01. 
GPEe: 1-alkyl-2-acyl glycerophosphoethanolamine; PlsE: Ethanolamine plasmalogen; 
PtdE: Phosphatidylethanolamine; R: ratio of peak area of endogenous lipid to the peak area of the internal standard.
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Identification of unknowns
The exact masses of unknown metabolites were used to 
interrogate public databases for compound identifica-
tion. These databases included LipidMaps, hmdb and 
Kegg. Putative metabolites were subsequently validated 
by MS2. Putative aldehyde metabolites were derivatized 
with Girard’s reagent T (GRT). To the dried methyl-
tert-butyl ether extracts, added 0.1 ml of reagent 
(20 mg GRT per ml of methanol) and 20 μl of acetic 
acid prior to heating at 70°C for 30 min with shaking. 
The samples were dried and dissolved in infusion sol-
vent. Aldehydes were augmented in mass by 113.09528 
after derivatization with GRT and the [M+H]+ ions of 
these derivatives were monitored in ESI.
Statistics
Data were analyzed utilizing the two-tailed t-test 
assuming unequal variances (Excel).
Results
Gender differences
There were no gender differences in the umbilical cord 
plasma levels of lipids or sterol sulfates between new-
born males and females. However, this study had only 
three samples for each gender.
(O-acyl) Ω-hydroxy-fatty acids
(O-acyl) Ω-hydroxy-fatty acids, previously detected in 
amniotic fluid [3], were not detected in human cord blood.
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Figure 3. Umbilical cord serum levels of phosphatidylinositols and phosphatidylglycerols. Mean ± SD. The 
nomenclature refers to the fatty acid substitutions at sn-1 and sn-2 of the glycerol backbone. For example, 34:3 
refers to 34 carbons with three double bonds.  
*p < 0.01.  
PtdG: Phosphatidylglycerol; PtdI: Phosphatidylinositol; R: Ratio of peak area of endogenous lipid to the peak area 
of the internal standard.
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Choline glycerophospholipids
Cord serum was observed to possess a similar diver-
sity of diacylglycerophosphocholines (phosphatidyl-
cholines) and PlsCh as monitored in adult serum 
(Figure 1). A number of choline glycerophospho-
lipids were monitored at 50–80% lower levels in 
cord serum, except for lipids with polyunsaturated 
fatty acid s ubstitutions with six to nine unsaturated 
bonds.
Ethanolamine glycerophospholipids
Phosphatidylethanolamines, alkyl-acyl-phosphatidyl-
ethanolamines and PlsE were 50–70% lower in cord 
serum than in adult serum (Figure 2).
Phosphatidylinositols & phosphatidylglycerols
PtdIn levels were generally lower in cord serum while 
PG levels were 50–60% less than measured in adult 
serum (Figure 3).
Figure 4. Umbilical cord serum levels of diacylglycerols and triacylglycerols. Mean ± SD. The nomenclature refers 
to the fatty acid substitutions of the glycerol backbone. For example, 34:1 refers to 34 carbons with one double 
bond. 
*p < 0.01.  
DAG: Diacylglycerol; R: ratio of peak area of endogenous lipid to the peak area of the internal standard; 
TAG: Triacylglycerol.
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Neutral lipids
DAG and TAG levels were 50–80% lower in cord 
serum (Figure 4).
Sphingolipids
SM and ceramide levels were similar for cord and adult 
serum with few exceptions showing lower levels in cord 
blood (Figure 5).
Free fatty acids
Free fatty acid levels of cord serum were similar to 
those monitored in adult serum (Figure 6).
Sterol sulfates
Cord serum was found to contain a diverse array of 
neurosteroid sulfates not detected in adult serum 
(Figure 6). These included pregnenolone sulfate, 
hydroxypregnenolone sulfate, allopregnanolone sul-
fate and tetrahydrodeoxycorticosterone sulfate. Dehy-
droepiandrosterone sulfate was detected in both cord 
and adult plasma, but shotgun lipidomics cannot 
distinguish dehydroepiandrosterone sulfate from 
t estosterone sulfate.
The bile acids, taurodeoxycholic acid and glycoche-
nodeoxycholic acid sulfate were found at lower levels 
Figure 5. Umbilical cord serum levels of sphingolipids. Mean ± SD. The nomenclature refers to the fatty acid 
substitution of the sphingosine backbone. For example, 16:0 refers to palmitic acid.   
* p < 0.01.  
Cer: Ceramide; R: Ratio of peak area of endogenous lipid to the peak area of the internal standard; 
SM: Sphingomyelin.
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in cord serum than in adult serum. However, several 
sulfates of bile acid intermediates were only detected 
in cord serum. MS2 of the sterol sulfates all yielded a 
strong product anion of 96.9595 [HSO
4
]- with 0.10–
0.21 ppm mass error, supporting that these biomark-
ers were sulfates. The monitored [M-H]- anion of 
497.2942 could be dihydroxycholesterol sulfate, cho-
lestenetriol sulfate (24 and 25 triol) and/or dihydroxy-
cholestanal sulfate. Derivatization with GRT did not 
alter the mass of 497.2942, eliminating the possibility 
that this sterol sulfate was the aldehyde. Therefore, the 
mass 497.2942 is most likely dihydroxycholesterol sul-
fate in the acidic pathway and/or cholestenetriol sul-
fates (24/25 triols) in the hydroxylase pathways of bile 
acid biosynthesis.
Similarly, the [M-H]- anion of 513.2892 could be 
dihydroxycholestanoate sulfate and/or trihydroxy-
cholestanal sulfate. Derivatization with GRT did not 
alter the mass of 513.2892, eliminating the possibility 
that this sterol sulfate was the aldehyde. Therefore, the 
mass 513.2892 is most likely dihydroxycholestanoate 
sulfate in the neutral pathway of bile acid biosynthesis.
Perfluoroalkyl environmental/industrial toxins
The industrial toxins and perfluoro-octane sulfonate 
(PFOS), perfluorononanoic acid, perfluoro-octanoic 
acid and perfluorohexane sulfonic acid were found in 
adult serum, while only PFOS and perfluorononanoic 
acid were detected in cord serum, albeit at much lower 
concentrations in the case of PFOS (Table 1). MS2 of 
PFOS and perfluorohexane sulfonic acid yielded a 
strong product anion of 79.9568 [SO
3
]- with 2.12 ppm 
mass error, supporting that these were sulfonic acids.
Discussion
As limited analyses of the umbilical cord serum lipi-
dome have previously been available [1,2], we undertook 
a detailed lipidomics analysis of cord serum. Unsurpris-
ingly, we found that the umbilical cord serum lipidome 
is dominated by similar lipids to those circulating in the 
maternal serum. Our data indicate that in cord sera, 
the diversities of inositol, choline and ethanolamine 
glycerophospholipids are comparable to the diversities 
observed in adult sera, but that a number of these lipids 
are present at lower levels in the cord blood. Our data 
are the first to demonstrate the presence of 1-alkyl-2-
acyl glycerophosphoethanolamines (GPE 32:0e and 
GPE 34:0e) in cord sera. The lower levels of 1-alkyl-
2-acyl glycerophosphoethanolamines, PlsE and PlsC 
in cord blood strongly suggest that peroxisomal func-
tion, which is responsible for the biosynthesis of ether 
lipids [5], is active in the fetus [6] and that these vinyl-
ether lipids are not exported into the cord blood but are 
u tilized as essential membrane lipids by the fetus.
Cord sera also possessed significantly lower circulat-
ing levels of PtdG and PtdI than are present in adult 
sera. Similarly the neutral lipids (DAG and TAG) were 
much lower in cord sera. This may indicate that the 
fetal liver biosynthesis of these lipids is sufficient for 
fetal metabolism but not for export to the cord blood. 
Our data also suggest that the fetal liver is the main 
source of DAG and TAG essential for energy metabo-
lism, signal transduction and biosynthesis of glycero-
lipids and gl ycerophospholipids [4].
The levels of free fatty acids and the sphingolipid 
lipidome profile (levels of SM and ceramides) of the 
cord sera were comparable to the ones observed in adult 
sera. These data possibly imply that free fatty acids and 
sphingolipids may pass freely between maternal and 
fetal circulations.
Bile acids of the cord sera are generally considered 
to derive from the fetus rather than the mother [7,8]. 
Polyhydroxylated bile acids and bile acid sulfates are 
not present in nonpregnant healthy adults, but appear 
in the serum of patients with inborn errors of bile acid 
metabolism [8–10] or with cholestatic liver diseases [7]. 
During pregnancy, polyhydroxylated bile acids pro-
duced by the fetal liver are transported via cord blood 
to the mother for further metabolism and elimina-
tion [7,8]. Concentrations of these polyhydroxylated 
bile acids decrease in healthy infants between the age 
of 7 years and 30 days postpartum [11]. Our data dem-
onstrate that sulfates of some of these polyhydroxylated 
bile acids are excreted into the cord blood, presumably 
via the cations of cytosolic sulfotransferases which cat-
alyze sulfation of hydroxylated sterols [9]. Specifically, 
sterol sulfates, including cholestenetriol and dihy-
droxycholestanoate sulfates, were not detected in the 
sera of the nonpregnant adult females. Elevated levels 
Figure 6. Umbilical cord serum levels of free fatty acids. 
Mean ± SD. 
*p < 0.01. 
FFA: Free fatty acid; R: Ratio of peak area of endogenous 
lipid to the peak area of the internal standard. 
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of these bile acid sulfates have been reported in infants 
with hydroxysteroid dehydrogenase deficiency [9–12] 
indicating that these may be useful biomarkers for 
abnormal fetal liver development.
Even though cord neurosteroids have been sug-
gested to originate from the mother rather than the 
fetus [13–17], we observed that in the cord blood there 
were a number of neurosteroid sulfates which were 
absent in the adult sera. Supply of neurosteroids and 
neurosteroid sulfates is critical for the neurological 
development of the fetus, since they are potent mod-
ulators of GABAergic neuronal transmission [18,19] 
and are involved in synaptic plasticity and neuronal 
development [19–21]. It remains to be determined if the 
neurosteroid sulfates we monitored originate from the 
fetus or from the mother.
We confirmed previous findings that perfluoro-
alkyl-containing environmental toxins are present 
both in cord sera and in adult sera [22–26]. Analyz-
ing cord blood for perfluoroalkyl toxins may be a 
useful means of determining fetal exposure to these 
carcinogenic environmental toxins, which have a 
detrimental effect on birthweight and sexual devel-
opment of the fetus and young infant. The major 
limitation of this study is the small sample size. In 
addition, chromatographic methods should be uti-
lized next to validate the identification of the sterols 
and p erfluoroalkyl compounds.
Conclusion
In summary, our pilot study significantly expands our 
knowledge database for the lipidome of human cord 
sera and suggests that several potential biomarkers are 
worthy of further study. These include bile acid sul-
fates as potential biomarkers of abnormal fetal liver 
function, neurosteroid sulfates as potential biomarkers 
of fetal neural development and perfluoroalkyl-con-
taining environmental toxins as potential biomarkers 
of fetal risks for slow development and early cancer 
development.
Future perspective
These data suggest that future studies of bile acid sul-
fates during in utero and postpartum development may 
lead to new diagnostics for evaluating normal versus 
abnormal liver development. Inclusion of pregnant and 
nonpregnant females also will be valuable comparisons 
in future studies.
Table 1. Sterol sulfates and environmental perfluoroalkyl toxins monitored in adult and umbilical cord serum.
Sterol sulfate or perfluoroalkyl toxin Calculated [M-H]- Observed ppm Adult serum Cord serum
   Mean ± SD (range) Mean ± SD (range)
Cholesterol sulfate 465.3044 0.68 0.94 ± 0.13 1.11 ± 0.29
DHEAS/testosterone sulfate 367.1585 0.94 0.86 ± 0.36 1.40 ± 0.13†
Pregnenolone sulfate 395.1898 0.39 ND 0.89 ± 0.18
Hydroxypregnenolone sulfate 411.1847 1.48 ND 0.86 ± 0.26
Allopregnanolone sulfate 397.2054 1.75 ND 0.84 ± 0.035
THDOC sulfate 413.2003 1.92 ND 0.67 ± 0.093
Glycochenodeoxycholic acid sulfate 528.2637 1.82 0.43 ± 0.12 0.18 ± 0.057†
Taurodeoxycholic acid 498.2895 1.19 0.14 ± 0.016 0.085 ± 0.019†
Cholestenetriol/dihydroxycholesterol 
sulfate
497.2942 1.19 ND 0.42 ± 0.096
Dihydroxycholestanoate sulfate 513.2892 1.05 ND 0.20 ± 0.029
Perfluoro-octane sulfonic acid 498.9302 1.23 2.30 ± 1.9 
(0.55–5.0)
0.39 ± 0.08† 
(0.30 – 0.50)
Perfluorononanoic acid 462.9632 1.91 0.44 ± 0.19 
(0.31–0.71)
0.24 ± 0.10 
(0.11–0.36)
Perfluorooctanoic acid 412.9664 0.93 0.36 ± 0.35 
(0.04–0.96)
ND
Perfluorohexane sulfonic acid 398.9366 0.97 0.41 ± 0.34 
(0.11–0.98)
ND
Values (mean ± SD) represent the ratio of the peak area of the endogenous sterol sulfate/peak area of 100 pmol of the internal standard [2H7]cholesterol sulfate per 
0.1 ml of cord serum.  
†p < 0.05 vs adult plasma.
DHEAS: Dehydroepiandrosterone sulfate; ND: Not detected; ppm: Parts per million mass error; THDOC: Tetrahydrodeoxycorticosterone. 
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